Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
W. L. Gore & Associates, Inc. Receives U.S. Food & Drug Administration (FDA) Approval For Lower Profile Gore® VIABAHN® VBX Balloon Expandable Endoprosthesis, Now 6 Fr Sheath Compatible
01/31/2024
With improvements to the stent graft delivery system enabling a 1 Fr profile reduction  on the majority of sizes, the device now offers the most 6 Fr compatible configurations among balloon expandable stent grafts. FLAGSTAFF, Ariz....
With improvements to the stent graft delivery system enabling a 1 Fr profile reduction  on the majority of sizes, the device now offers the most 6 Fr compatible configurations among balloon expandable stent grafts. FLAGSTAFF, Ariz....
With improvements to the stent...
01/31/2024
Vascular Disease Management
News
First Patient Treated in the Clinical Study of the ZENITH® FENESTRATED+ Endovascular Graft
01/31/2024
Cook Medical announced the first patient treated in the clinical study of the ZENITH® FENESTRATED+ Endovascular Graft (ZFEN+) in the United States.
Cook Medical announced the first patient treated in the clinical study of the ZENITH® FENESTRATED+ Endovascular Graft (ZFEN+) in the United States.
Cook Medical announced the first...
01/31/2024
Vascular Disease Management
News
Gore Receives FDA Approval for Breakthrough Endovascular Device in Complex Aortic Aneurysms
01/25/2024
The GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis approval brings the first branched, all-in-one solution for patients with thoracoabdominal aortic aneurysms and high-surgical risk patients with pararenal aortic aneurysms in patients...
The GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis approval brings the first branched, all-in-one solution for patients with thoracoabdominal aortic aneurysms and high-surgical risk patients with pararenal aortic aneurysms in patients...
The GORE® EXCLUDER®...
01/25/2024
Vascular Disease Management

Advertisement

News
First Patients Enrolled in the Gore VBX Forward Clinical Study
01/18/2024
This study aims to compare the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease with the goal of informing practice guidelines...
This study aims to compare the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease with the goal of informing practice guidelines...
This study aims to compare the...
01/18/2024
Vascular Disease Management
News
Nectero Medical Announces Initiation of Phase II/III Clinical Trial of the Nectero EAST® System for Treatment of Small- to Medium-Sized Abdominal Aortic Aneurysms
01/18/2024
Trial to randomize 400 subjects at multiple sites, primarily in the U.S., to evaluate safety and efficacy of the investigational Nectero EAST System for treatment of infrarenal AAA, maximum diameter 3.5-5.0cm TEMPE, Ariz., January 18,...
Trial to randomize 400 subjects at multiple sites, primarily in the U.S., to evaluate safety and efficacy of the investigational Nectero EAST System for treatment of infrarenal AAA, maximum diameter 3.5-5.0cm TEMPE, Ariz., January 18,...
Trial to randomize 400 subjects...
01/18/2024
Vascular Disease Management
News
Reflow Medical Receives CE Mark for Bare Temporary Spur Stent System for Treating de novo or Restenotic Below-the-Knee (BTK) Lesions
01/15/2024

Reflow Medical News

Reflow Medical News
Reflow Medical's Bare Temporary Spur Stent System is intended to treat de novo or restenotic lesions in the infrapopliteal arteries with a commercially available drug-coated balloon (DCB) to enhance drug absorption.
Reflow Medical's Bare Temporary Spur Stent System is intended to treat de novo or restenotic lesions in the infrapopliteal arteries with a commercially available drug-coated balloon (DCB) to enhance drug absorption.
Reflow Medical's Bare Temporary...
01/15/2024
Cath Lab Digest

Advertisement

News
Multidisciplinary Panel of Experts From Prominent Cardiovascular Societies Advocate for Broader Adoption of IVUS in Peripheral Interventions to Improve Patient Care
01/11/2024
Advantages of IVUS include identification of plaque burden and morphology, lesion characteristics, and stent sizing and positioning, which translate into improvements in procedural safety and long-term patient outcomes.
Advantages of IVUS include identification of plaque burden and morphology, lesion characteristics, and stent sizing and positioning, which translate into improvements in procedural safety and long-term patient outcomes.
Advantages of IVUS include...
01/11/2024
Cath Lab Digest
Slip-Cath Beacon Tip (Cook Medical)
News
Slip-Cath® Beacon® Tip is Now Available in the U.S. and Canada
01/08/2024

Cook Medical News

Cook Medical News
Slip-Cath is a hydrophilic angiographic catheter used in vascular and non-vascular procedures.
Slip-Cath is a hydrophilic angiographic catheter used in vascular and non-vascular procedures.
Slip-Cath is a hydrophilic...
01/08/2024
Cath Lab Digest
News
Gore Announces First Patient Implant in the Arise II Pivotal Study of the GORE® Ascending Stent Graft
12/20/2023
CAUTION: Investigational device. Limited by United States law to investigational use. The first patient implant in the ARISE II Pivotal Study evaluation of the GORE® Ascending Stent Graft represents a major milestone in the development of...
CAUTION: Investigational device. Limited by United States law to investigational use. The first patient implant in the ARISE II Pivotal Study evaluation of the GORE® Ascending Stent Graft represents a major milestone in the development of...
CAUTION: Investigational device....
12/20/2023
Vascular Disease Management

Advertisement

News
Finding a Faster Path to Treatment for Stroke
12/13/2023
Milestone enrollment marks major progress in Philips-sponsored WE-TRUST clinical trial assessing the patient benefits of the ‘Direct to Angio Suite’ treatment pathway December 12, 2023  - On November 29, the WE-TRUST* study – a...
Milestone enrollment marks major progress in Philips-sponsored WE-TRUST clinical trial assessing the patient benefits of the ‘Direct to Angio Suite’ treatment pathway December 12, 2023  - On November 29, the WE-TRUST* study – a...
Milestone enrollment marks major...
12/13/2023
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Sleep and CVD
Study of Sleep in Women Shows Delaying Bedtime by Just 90 Minutes Each Night Damages Endothelial Cells
08/06/2024
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of...
08/06/2024
Cath Lab Digest
Peripheral Interventions
VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
07/30/2024
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has...
07/30/2024
Cath Lab Digest
Peripheral Interventions
Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure
07/30/2024
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a...
07/30/2024
Cath Lab Digest
Carotid Artery Revascularization
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
07/30/2024
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery...
07/30/2024
Cath Lab Digest
Health Care Needs
JACC: Almost Half of U.S. Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
07/29/2024
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S....
07/29/2024
Cath Lab Digest
Renal Denervation
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation
07/25/2024
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on...
07/25/2024
Cath Lab Digest
Ischemic Stroke
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
07/24/2024
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all...
07/24/2024
Cath Lab Digest
LINC
News
HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier...
07/22/2024
Vascular Disease Management
News
Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology
07/17/2024
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF...
07/17/2024
Vascular Disease Management
Ischemic Stroke
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
07/17/2024
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the...
07/17/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use